John Maraganore

Discovers and develops therapeutics

Engages in the research, development, manufacturing and marketing of pharmaceutical products

Develops and commercializes antibody-based therapeutics for the treatment of cancer

Develops next generation products based on the transformative potential of gene therapy

Atlas Venture Advisors invests in companies located in the United States. The firm focuses on life sciences and biotech sectors. It provides financing for early stage capital requirements.

Develops and commercializes therapeutics based on RNA interference

Functions as a College/University

Develops pharmaceutical products

Provides investment and fund management services

Operates as a biopharmaceutical company that engages in discovering and developing of drugs

Manufactures bio-chemicals

Longwood Fund invests in companies located in the United States. The firm focuses on the healthcare sector. It participates in early stage capital transactions.

Omega Fund Management invests in private and public companies located in the US and Europe. The firm focuses on sectors such as biotechnology, life sciences, healthcare and medical devices. It provides financing for seed, early, mid and later stage capital requirements. It makes direct secondary investments along with follow-on investments.

Entree Capital invests in companies located across the globe, primarily in Israel. The firm targets companies operating in the fields of SaaS, data, fintech, security, productivity and consumer. It provide financing for pre-seed, seed, early, later and buyout stage companies with an investment size of USD 0.25 - 3 million and also makes follow-on investments.

Develop next-generation therapies that selectively suppress Th17-cells and enhance specialized Treg cells

Operates as a biotechnology company that develops immunology medicines for health problems

Operate as a biotechnology company that develops precision genetic medicines, gene editing and delivery technologies

Provides hospital and healthcare services

Develops antibodies for the treatment of rare bleeding disorders

The Termeer Foundation is a nonprofit organization dedicated to empowering life science innovators and leaders to accelerate the development of patient-centered healthcare solutions. The private company is based in Boston. It offers leadership programs, including the Termeer Fellows Program, which supports first-time CEOs of early-stage or nonprofit biotech organizations through mentorship, executive coaching, and networking. The foundation fosters a diverse and inclusive community of entrepreneurs, academics, and students, and maintains a network of mentors, advisors, and alumni to strengthen collaboration and innovation. The American company was founded by Alan E. Walts.

Operates as a clinical-stage biopharmaceutical company

Provides healthcare and biotechnology services

Engages in discovery & development of antibodies and small molecule antivirals against SARS-CoV-2 and other epidemic & pandemic threats

Operates as a clinical-stage biotechnology company

Operates as a biotechnology company that develops RNA-based medicines

Operates as a clinical-stage, neuroscience-focused company that develops rapid-acting treatments for neuropsychiatric diseases

Operates as an clinical-stage biotechnology company that engages in discovery and development of medicines for neurological disorder

Engages in research and development of prophylactic therapeutics for bleeding disorders